Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A
Clinical trial NCT04845399 · COMPLETED
Trial details
- NCT number
- NCT04845399
- Sponsor
- Zhengzhou Gensciences Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2021-06-26
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.